ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Flagship Pioneering, Inc.
The Director, Modeling and Simulation leads and supports modeling efforts across Flagship Pioneering's drug discovery portfolio, partnering with internal and external teams to translate scientific ideas into therapies. This role involves providing strategic guidance for due diligence, early feasibility, and clinical development while managing a team of modeling scientists and external partners. The position requires deep expertise in mechanistic modeling, strong analytical skills, and the ability to work in a dynamic, cross-functional environment.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2000
Flagship Pioneering is a venture creation and investment firm that invents, builds, and funds early-stage companies in biotechnology, life sciences, and sustainability. Using an integrated model of in-house science, lab infrastructure, capital, and operational support, it spins out and scales breakthrough ventures — it has helped found more than 100 companies, including high-profile names such as Moderna. Flagship focuses on deep‑science innovation and long‑term partnerships to translate novel discoveries into transformative products for human health and the planet.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Flagship Pioneering, Inc..
individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week
Jul 20, 2025
Scientific Director
Eli Lilly and Company
Director, Clinical Pharmacology, Modeling and Simulation
Amgen
Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation
GSK plc
QSP/QST Modeling Scientist
Jobgether
Scientific Associate Director, Clinical Pharmacology
Amgen
Principal Scientist of Translational PK/PD Modeling
Regeneron Pharmaceuticals
